Lycium barbarum/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Lycium barbarum — no detected effect on serum leptin
Evidence strength: moderate.FindingNull result“There were no significant differences in ADPN (P>0.05), leptin (before intervention: Z=-0.587, P=0.557; three months later: Z=-0.439, P=0.661) and IL-6 (before intervention: Z=-0.708, P=0.479; three months later: Z=-1.377, P=0.169) between placebo and LBP groups after LBP administration.”
Quoted verbatim from Practical Application of Antidiabetic Efficacy of Lycium barbarum Polysaccharide in Patients with Type 2 Diabetes.. - Study
- RCT
- Dose
- one capsule of 150 mg LBP plus 150 mg microcrystalline cellulose twice daily (300 mg/day)
- Population
- Adults with type 2 diabetes of under 5 years, 37 on LBP and 30 on placebo, 3 months; value at 0 h of the oral meal tolerance test
Practical Application of Antidiabetic Efficacy of Lycium barbarum Polysaccharide in Patients with Type 2 Diabetes.2015PMID:2538199510.2174/1573406410666141110153858Permalink
To cite this finding: https://catalystproject.ai/e/01M5MZ1YR84GFVXJRW4FGT35WS